MEF2A and pachyonychia congenita: Interestingly, this pre‐study revealed that myocyte enhancer factor 2A (MEF2A) acted as an upstream transcription factor of PSMD14, and silencing MEF2A significantly downregulated PSMD14 expression in PC cells.